Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013-14) trial.
Rieneke T LugtenbergStefanie de GrootAd A KapteinMaarten J FischerElma Meershoek-Klein KranenbargMarjolijn Duijm-de CarpentierDanielle CohenHiltje de GraafJoan B HeijnsJohanneke E A PortieljeAgnes J van de WouwAlex L T ImholzLonneke W KesselsSuzan VrijaldenhovenArnold BaarsMarta FioccoJacobus J M van der HoevenHans GelderblomValter D LongoHanno PijlJudith R Kroepnull nullPublished in: Breast cancer research and treatment (2020)
FMD as an adjunct to neoadjuvant chemotherapy appears to improve certain QoL and illness perception domains in patients with HER2-negative breast cancer. Trialregister ClinicalTrials.gov Identifier: NCT02126449.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- lymph node
- sentinel lymph node
- healthcare
- primary care
- study protocol
- physical activity
- phase iii
- blood glucose
- weight loss
- clinical trial
- insulin resistance
- rectal cancer
- squamous cell carcinoma
- phase ii
- randomized controlled trial
- radiation therapy
- type diabetes
- glycemic control